Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states
about
The continuing challenges of leprosyTumor necrosis factor production in patients with leprosyImmunohistological analysis of in situ expression of mycobacterial antigens in skin lesions of leprosy patients across the histopathological spectrum. Association of Mycobacterial lipoarabinomannan (LAM) and Mycobacterium leprae phenolic glycolipid-Comparison of Efficacy and Safety of Ciclosporin to Prednisolone in the Treatment of Erythema Nodosum Leprosum: Two Randomised, Double Blind, Controlled Pilot Studies in EthiopiaThe influence of innate and adaptative immune responses on the differential clinical outcomes of leprosy.Potential plasma markers of Type 1 and Type 2 leprosy reactions: a preliminary reportPredicting neuropathy and reactions in leprosy at diagnosis and before incident events-results from the INFIR cohort study.Regulation of murine macrophage effector functions by lipoarabinomannan from mycobacterial strains with different degrees of virulence.In Situ complement activation and T-cell immunity in leprosy spectrum: An immunohistological study on leprosy lesional skinA tumor necrosis factor mimetic peptide activates a murine macrophage cell line to inhibit mycobacterial growth in a nitric oxide-dependent fashionSoluble tumor necrosis factor alpha receptors in sera from leprosy patients.Reactions following completion of 1 and 2 year multidrug therapy (MDT).Circulating levels of insulin-like growth factor-I (IGF-I) correlate with disease status in leprosy.Up-regulation of Th1-type responses in mucosal leishmaniasis patientsStatins increase rifampin mycobactericidal effect.Leprosy and the human genomeMycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview.Classification of current anticancer immunotherapiesHuman polymorphisms as clinical predictors in leprosyViral Co-infection and Leprosy Outcomes: A Cohort Study.Therapeutic potential for cytokine antagonists: Thalidomide and pentoxifylline in Hansen's disease.Role of TEFFECTOR/MEMORY Cells, TBX21 Gene Expression and T-Cell Homing Receptor on Type 1 Reaction in Borderline Lepromatous Leprosy Patients.Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patientsLeprosy reactions: coinfections as a possible risk factor.Antigen-specific T-cell responses of leprosy patientsA Systematic Review of Immunological Studies of Erythema Nodosum Leprosum.Serial measurement of the circulating levels of tumour necrosis factor and its soluble receptors 1 and 2 for monitoring leprosy patients during multidrug treatment.Leprosy: an overview of pathophysiologyEffects of prednisolone treatment on cytokine expression in patients with leprosy type 1 reactions.Serum levels of interferon-gamma, tumour necrosis factor-alpha, soluble interleukin-6R and soluble cell activation markers for monitoring response to treatment of leprosy reactions.IgG1 antimycobacterial antibodies can reverse the inhibitory effect of pentoxifylline on tumour necrosis factor alpha (TNF-alpha) secreted by mycobacterial antigen-stimulated adherent cells.Genetic polymorphisms of the IL6 and NOD2 genes are risk factors for inflammatory reactions in leprosyEtanercept in erythema nodosum leprosum.Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis.Trial Watch: Lenalidomide-based immunochemotherapy.Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.Induction of apoptosis in monocytes by Mycobacterium leprae in vitro: a possible role for tumour necrosis factor-alpha.Autophagy Impairment Is Associated With Increased Inflammasome Activation and Reversal Reaction Development in Multibacillary Leprosy.
P2860
Q24545809-EB43F88A-93DB-4FAA-8A72-5784EA38AF03Q24650697-A60FD966-1C47-473E-A0DD-091AA8AEF270Q28343370-A97C6018-D9BF-4EB0-A14F-D227C1E5C51BQ28550415-92059F90-E5F8-4330-BB9B-334650C3CCB4Q30238551-E43EA3E7-C8F7-48A1-AD1F-EE23EBC0A8D8Q33454062-26CEA923-8B54-4484-A94D-34FA793CF6A8Q33492297-7CF3FD75-5696-4100-B7CF-52F134E83F03Q33610521-9A77CD5A-0C97-4D61-97B8-7D53BDD36C2FQ33688349-BBAA4CC6-502D-48CF-ADCB-EE5987A75A14Q33753828-08760C70-94C4-45FC-B72C-198AE55679DEQ34000080-41C21144-5B14-4A8D-820C-0F4B7F9E58BFQ34087450-B0E6ECD8-680F-4C7F-A934-FA786E8D065AQ34099919-0A17F67B-CB21-422D-BA81-A33567EF63E9Q34259236-D90D7EA1-8B2D-4166-A70D-11342828576CQ34299149-6DBC9458-F71B-439A-B04A-C9ECD8D4BC5AQ34431856-2728AC3F-1091-48D0-BFB8-C3D7A9D3E9E2Q35070041-DC00716C-B729-415C-9E4A-D30D5FAFBF5AQ35149637-C7F18585-0875-4BC3-9E95-55392AA89204Q35636319-30848378-F3D3-4B68-8B18-C0A69E9CBF04Q35744206-776C796D-6B5D-4DB3-AE83-8B2A6783A19BQ35892890-CF0FEEC9-D3CD-49A6-9B7D-FAE88A7C508EQ36169102-3C78229F-7A1D-4B19-BC1F-C5A3AEC2A98CQ36231351-73F8B34F-4306-4801-8C01-FFCB997027C7Q36284796-0276D5A3-D2E3-4337-BD2F-6D27465A591CQ36974307-E0ACEAD3-A71B-4521-B4F7-67CC1642BEA9Q37695062-34AD4AD6-CEEC-4283-B7E3-8DFC6D737BAEQ37734139-7D3072E0-B953-4B0A-9CFF-78C9AC5AFCDCQ38044386-899A46BF-6C3C-4E18-91BB-81DC49E875EFQ38874908-FB3DDD4D-578C-4A3B-8FD3-004B1FC89168Q40163734-1577A788-61B3-43D7-90FE-8FD4A604B398Q40535859-BF22EE79-F9D3-448D-B276-3C2A4A82B969Q41154742-7B5E74CD-76A2-4C45-BF4B-C1D262BC6079Q41680121-C58E504C-CA13-4C63-92B6-179858545E11Q41874546-4DC89CB9-AB6E-4DBE-B8F3-A354640E5397Q42737828-6007B804-EF71-4FB2-9A2D-6E954761435BQ42941758-BE351E1B-BEAD-454E-8F4A-11BC163F2BFCQ44412691-DE78B2F6-DFEE-42AF-AB41-FF16E00B5D64Q55262167-49690621-F212-4D5D-AE0D-46CC81D5C450
P2860
Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states
description
1991 nî lūn-bûn
@nan
1991 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Serum levels of tumour necrosi ...... ring leprosy reactional states
@ast
Serum levels of tumour necrosi ...... ring leprosy reactional states
@en
Serum levels of tumour necrosi ...... ring leprosy reactional states
@nl
type
label
Serum levels of tumour necrosi ...... ring leprosy reactional states
@ast
Serum levels of tumour necrosi ...... ring leprosy reactional states
@en
Serum levels of tumour necrosi ...... ring leprosy reactional states
@nl
prefLabel
Serum levels of tumour necrosi ...... ring leprosy reactional states
@ast
Serum levels of tumour necrosi ...... ring leprosy reactional states
@en
Serum levels of tumour necrosi ...... ring leprosy reactional states
@nl
P2093
P2860
P921
P3181
P1476
Serum levels of tumour necrosi ...... ring leprosy reactional states
@en
P2093
P2860
P3181
P356
10.1111/J.1365-2249.1991.TB08131.X
P407
P577
1991-04-01T00:00:00Z